Initial phaco for angle-closure glaucoma climbed to 48.4% in adults 50 and older, while surveys and IRIS data show shifting ...
A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help ...
Taking cholesterol-busting statin drugs may be protecting people from glaucoma, says a new study from UCSD Medical School.
Researchers in Dublin report that the enzyme autotaxin and its lipid product lysophosphatidic acid drive fibrosis in lamina ...
The Bimatoprost Drug Pad-IOL (BIM-IOL) System, developed by SpyGlass Pharma, uses 2 drug-eluting pads attached to the lens to ...
A case has been published where an internal evaluation AI at OpenAI, unable to find the files required for grading, attempted ...
Roche’s vamikibart shows 1-year vision gains in Phase 3 uveitic macular edema trials, offering a non-steroid alternative; see ...
The stock is priced for years of flawless execution, which is why I think GKOS GKOS--is an excellent company but not an ...
This is an introduction to the Amazon bestseller 'The Pathophysiology You Taught Me Back Then'.This book is designed to help you understand pathology and physiology not as subjects to be memorized, ...
On October 11, 2026, AGLD rose by 0.2% within 24 hours to reach $0.2166. AGLD dropped by 2.96% within 7 days, dropped by 0.73 ...
Glaukos has the iDose TR, which moves it beyond surgical devices into sustained drug delivery. Read why I lean neutral on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results